Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Erratum: Cuceu, C., et al. Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability. Cancers 2018, 10, 233.

Cuceu C, Colicchio B, Jeandidier E, Junker S, Plassa F, Shim G, Mika J, Frenzel M, Al Jawhari M, Hempel WM, Kabacik S, Lenain A, Morat L, Girinsky T, Dieterlen A, Polanska J, Badie C, Carde P, M'Kacher R.

Cancers (Basel). 2019 May 30;11(6). pii: E757. doi: 10.3390/cancers11060757.

2.

Establishment and Characterization of a Reliable Xenograft Model of Hodgkin Lymphoma Suitable for the Study of Tumor Origin and the Design of New Therapies.

M'kacher R, Frenzel M, Al Jawhari M, Junker S, Cuceu C, Morat L, Bauchet AL, Stimmer L, Lenain A, Dechamps N, Hempel WM, Pottier G, Heidingsfelder L, Laplagne E, Borie C, Oudrhiri N, Jouni D, Bennaceur-Griscelli A, Colicchio B, Dieterlen A, Girinsky T, Boisgard R, Bourhis J, Bosq J, Mehrling T, Jeandidier E, Carde P.

Cancers (Basel). 2018 Oct 31;10(11). pii: E414. doi: 10.3390/cancers10110414.

3.

Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal Instability .

Cuceu C, Colicchio B, Jeandidier E, Junker S, Plassa F, Shim G, Mika J, Frenzel M, Al Jawhari M, Hempel WM, O'Brien G, Lenain A, Morat L, Girinsky T, Dieterlen A, Polanska J, Badie C, Carde P, M'Kacher R.

Cancers (Basel). 2018 Jul 13;10(7). pii: E233. doi: 10.3390/cancers10070233. Erratum in: Cancers (Basel). 2019 May 30;11(6):.

4.

The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes.

M'kacher R, Cuceu C, Al Jawhari M, Morat L, Frenzel M, Shim G, Lenain A, Hempel WM, Junker S, Girinsky T, Colicchio B, Dieterlen A, Heidingsfelder L, Borie C, Oudrhiri N, Bennaceur-Griscelli A, Moralès O, Renaud S, Van de Wyngaert Z, Jeandidier E, Delhem N, Carde P.

Cancers (Basel). 2018 May 30;10(6). pii: E169. doi: 10.3390/cancers10060169.

5.

Transmission of Induced Chromosomal Aberrations through Successive Mitotic Divisions in Human Lymphocytes after In Vitro and In Vivo Radiation.

Kaddour A, Colicchio B, Buron D, El Maalouf E, Laplagne E, Borie C, Ricoul M, Lenain A, Hempel WM, Morat L, Al Jawhari M, Cuceu C, Heidingsfelder L, Jeandidier E, Deschênes G, Dieterlen A, El May M, Girinsky T, Bennaceur-Griscelli A, Carde P, Sabatier L, M'kacher R.

Sci Rep. 2017 Jun 12;7(1):3291. doi: 10.1038/s41598-017-03198-7.

6.

Genotoxic risk of ethyl-paraben could be related to telomere shortening.

Finot F, Kaddour A, Morat L, Mouche I, Zaguia N, Cuceu C, Souverville D, Négrault S, Cariou O, Essahli A, Prigent N, Saul J, Paillard F, Heidingsfelder L, Lafouge P, Al Jawhari M, Hempel WM, El May M, Colicchio B, Dieterlen A, Jeandidier E, Sabatier L, Clements J, M'Kacher R.

J Appl Toxicol. 2017 Jun;37(6):758-771. doi: 10.1002/jat.3425. Epub 2016 Dec 20.

PMID:
27995640
7.

Global quantification of γH2AX as a triage tool for the rapid estimation of received dose in the event of accidental radiation exposure.

Viau M, Testard I, Shim G, Morat L, Normil MD, Hempel WM, Sabatier L.

Mutat Res Genet Toxicol Environ Mutagen. 2015 Nov;793:123-31. doi: 10.1016/j.mrgentox.2015.05.009. Epub 2015 May 29.

8.

Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure.

M'kacher R, Girinsky T, Colicchio B, Ricoul M, Dieterlen A, Jeandidier E, Heidingsfelder L, Cuceu C, Shim G, Frenzel M, Lenain A, Morat L, Bourhis J, Hempel WM, Koscielny S, Paul JF, Carde P, Sabatier L.

Radiat Prot Dosimetry. 2015 Apr;164(1-2):134-7. doi: 10.1093/rpd/ncu296. Epub 2014 Oct 1.

PMID:
25274533
9.

Senescence-associated oxidative DNA damage promotes the generation of neoplastic cells.

Gosselin K, Martien S, Pourtier A, Vercamer C, Ostoich P, Morat L, Sabatier L, Duprez L, T'kint de Roodenbeke C, Gilson E, Malaquin N, Wernert N, Slijepcevic P, Ashtari M, Chelli F, Deruy E, Vandenbunder B, De Launoit Y, Abbadie C.

Cancer Res. 2009 Oct 15;69(20):7917-25. doi: 10.1158/0008-5472.CAN-08-2510. Epub 2009 Oct 13.

10.

Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites.

Gomez-Roca C, Raynaud CM, Penault-Llorca F, Mercier O, Commo F, Morat L, Sabatier L, Dartevelle P, Taranchon E, Besse B, Validire P, Italiano A, Soria JC.

J Thorac Oncol. 2009 Oct;4(10):1212-20. doi: 10.1097/JTO.0b013e3181b44321.

11.

Increased genomic alteration complexity and telomere shortening in B-CLL cells resistant to radiation-induced apoptosis.

Salin H, Ricoul M, Morat L, Sabatier L.

Cytogenet Genome Res. 2008;122(3-4):343-9. doi: 10.1159/000167821. Epub 2009 Jan 30.

12.

Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions.

Raynaud CM, Jang SJ, Nuciforo P, Lantuejoul S, Brambilla E, Mounier N, Olaussen KA, André F, Morat L, Sabatier L, Soria JC.

Ann Oncol. 2008 Nov;19(11):1875-81. doi: 10.1093/annonc/mdn405. Epub 2008 Jul 17.

PMID:
18641004
13.

Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.

Grenier J, Soria JC, Mathieu MC, Andre F, Abdelmoula S, Velasco V, Morat L, Besse B, Dunant A, Spielmann M, Delaloge S.

Anticancer Res. 2007 Jan-Feb;27(1B):547-55.

14.

High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.

Fizazi K, Morat L, Chauveinc L, Prapotnich D, De Crevoisier R, Escudier B, Cathelineau X, Rozet F, Vallancien G, Sabatier L, Soria JC.

Ann Oncol. 2007 Mar;18(3):518-21.

PMID:
17322541
15.

Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers.

Dutu T, Michiels S, Fouret P, Penault-Llorca F, Validire P, Benhamou S, Taranchon E, Morat L, Grunenwald D, Le Chevalier T, Sabatier L, Soria JC.

Ann Oncol. 2005 Dec;16(12):1906-14. Epub 2005 Oct 11.

PMID:
16219624
16.

Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis.

Dômont J, Pawlik TM, Boige V, Rose M, Weber JC, Hoff PM, Brown TD, Zorzi D, Morat L, Pignon JP, Rashid A, Jaeck D, Sabatier L, Elias D, Tursz T, Soria JC, Vauthey JN.

J Clin Oncol. 2005 May 1;23(13):3086-93.

PMID:
15860868
17.

Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.

Lantuejoul S, Soria JC, Morat L, Lorimier P, Moro-Sibilot D, Sabatier L, Brambilla C, Brambilla E.

Clin Cancer Res. 2005 Mar 1;11(5):2074-82.

18.

Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.

Erman M, Grunenwald D, Penault-Llorca F, Grenier J, Besse B, Validire P, Morat L, Girard P, Le Chevalier T, Sabatier L, Soria JC.

Lung Cancer. 2005 Mar;47(3):315-23.

PMID:
15713515
19.

Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome.

Spano JP, Andre F, Morat L, Sabatier L, Besse B, Combadiere C, Deterre P, Martin A, Azorin J, Valeyre D, Khayat D, Le Chevalier T, Soria JC.

Ann Oncol. 2004 Apr;15(4):613-7.

PMID:
15033669
20.

Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.

Lantuejoul S, Soria JC, Moro-Sibilot D, Morat L, Veyrenc S, Lorimier P, Brichon PY, Sabatier L, Brambilla C, Brambilla E.

Br J Cancer. 2004 Mar 22;90(6):1222-9.

21.

Loss of PTEN expression is not uncommon, but lacks prognostic value in stage I NSCLC.

Olaussen KA, Soria JC, Morat L, Martin A, Sabatier L, Morere JF, Khayat D, Spano JP.

Anticancer Res. 2003 Nov-Dec;23(6C):4885-90.

PMID:
14981940
22.

[Epidermal growth factor receptor and chemoprevention of epithelial tumor: rationale and development methods].

Masmoudi A, Fayette J, Slimane K, Temam S, Morat L, Soria JC.

Bull Cancer. 2003 Nov;90 Spec No:S251-6. Review. French.

PMID:
14763148
23.

Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients.

Ady N, Morat L, Fizazi K, Soria JC, Mathieu MC, Prapotnich D, Sabatier L, Chauveinc L.

Br J Cancer. 2004 Jan 26;90(2):443-8.

24.
25.

The molecular detection of circulating tumor cells in bladder cancer using telomerase activity.

Soria JC, Morat L, Durdux C, Housset M, Cortez A, Blaise R, Sabatier L.

J Urol. 2002 Jan;167(1):352-6.

PMID:
11743355
26.

Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis.

Soria JC, Morat L, Commo F, Dabit D, Perie S, Sabatier L, Fouret P.

Br J Cancer. 2001 Feb;84(4):504-11.

27.

Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.

Soria JC, Gauthier LR, Raymond E, Granotier C, Morat L, Armand JP, Boussin FD, Sabatier L.

Clin Cancer Res. 1999 May;5(5):971-5.

28.

Zinc transport and metallothionein induction in primary cultures of rabbit kidney proximal cells.

Gachot B, Tauc M, Wanstok F, Morat L, Poujeol P.

Biochim Biophys Acta. 1994 May 11;1191(2):291-8.

PMID:
8172914
29.

Zinc uptake by proximal cells isolated from rabbit kidney: effects of cysteine and histidine.

Gachot B, Tauc M, Morat L, Poujeol P.

Pflugers Arch. 1991 Dec;419(6):583-7.

PMID:
1788054

Supplemental Content

Support Center